7-92447889-G-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_021167.5(GATAD1):c.160G>A(p.Gly54Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.117 in 1,275,386 control chromosomes in the GnomAD database, including 8,931 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_021167.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GATAD1 | NM_021167.5 | c.160G>A | p.Gly54Ser | missense_variant | 1/5 | ENST00000287957.5 | NP_066990.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GATAD1 | ENST00000287957.5 | c.160G>A | p.Gly54Ser | missense_variant | 1/5 | 1 | NM_021167.5 | ENSP00000287957 | P1 | |
GATAD1 | ENST00000644160.1 | n.16G>A | non_coding_transcript_exon_variant | 1/2 | ||||||
GATAD1 | ENST00000645746.1 | c.160G>A | p.Gly54Ser | missense_variant, NMD_transcript_variant | 1/6 | ENSP00000493785 |
Frequencies
GnomAD3 genomes AF: 0.104 AC: 15848AN: 151870Hom.: 873 Cov.: 33
GnomAD3 exomes AF: 0.171 AC: 1200AN: 7038Hom.: 79 AF XY: 0.174 AC XY: 599AN XY: 3448
GnomAD4 exome AF: 0.119 AC: 133478AN: 1123410Hom.: 8060 Cov.: 31 AF XY: 0.119 AC XY: 64158AN XY: 537894
GnomAD4 genome AF: 0.104 AC: 15852AN: 151976Hom.: 871 Cov.: 33 AF XY: 0.104 AC XY: 7694AN XY: 74328
ClinVar
Submissions by phenotype
Dilated cardiomyopathy 2B Benign:4
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Benign, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | Jul 28, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | Phosphorus, Inc. | Aug 01, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 18, 2013 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 19, 2012 | p.Gly54Ser in Exon 01 of GATAD1: This variant is not expected to have clinical s ignificance because it has been identified in 9.4% (282/2994) of European Americ an chromosomes from a broad population by the NHLBI Exome Sequencing Project (ht tp://evs.gs.washington.edu/EVS; dbSNP rs10281879). - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Apr 10, 2015 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at